Articles published by Massive Bio, Inc.

Massive Bio and PrecisCa Announce Strategic Partnership to Expand Cancer Patient Access to Clinical Trials Across the U.S.

September 09, 2026

From Massive Bio, Inc.

Via Business Wire

Massive Bio Makes Inaugural Strategic Investment in Rivvi to Build an End-to-End AI Engagement Infrastructure for Healthcare

August 04, 2026

From Massive Bio, Inc.

Via Business Wire

Massive Bio and QC Healthcare Announce National Collaboration to Transform Cancer Patient Access

July 29, 2026

From Massive Bio, Inc.

Via Business Wire

Massive Bio and ONCOassist® Announce Strategic Partnership at ESMO 2023

October 19, 2023

From Massive Bio, Inc.

Via Business Wire

Massive Bio and NeoGenomics Announce Collaboration to Accelerate Oncology Drug Discovery and Improve Patient Care

March 22, 2023

From Massive Bio, Inc.

Via Business Wire

Tickers NEO

Massive Bio Raises $9 Million to Scale Growth and Fuel Global Expansion of Its AI-Enabled Oncology Clinical Trial Platform

June 02, 2022

From Massive Bio, Inc.

Via Business Wire

Massive Bio and Amber Specialty Pharmacy Announce Nationwide Partnership to Revolutionize Digitally Enabled Oncology Clinical Trial Recruitment through AI Technology Platform

May 03, 2022

From Massive Bio, Inc.

Via Business Wire

Massive Bio Hires Steve McNamara as Chief Operating Officer to Scale Global AI-Enabled Access to Cancer Clinical Trials and Further Maintain Record Growth

January 11, 2022

From Massive Bio, Inc.

Via Business Wire

Massive Bio Launches the Movement to Match 100,000 Cancer Patients to Clinical Trials: 100K SINGULARITY PROGRAM

December 07, 2021

From Massive Bio, Inc.

Via Business Wire

Massive Bio, Inc. to Partner With TheSocialMedwork to Help Cancer Patients Find Clinical Trials, Improve Health Outcomes and Accelerate the Adoption of Artificial Intelligence and Digital Health Solutions in Oncology

September 28, 2021

From Massive Bio, Inc.

Via Business Wire

Massive Bio, Inc. to Partner With Veterans Prostate Cancer Awareness and Self-Care Catalysts to Accelerate Clinical Trial Enrollment and Digital Health Solutions

August 31, 2021

From Massive Bio, Inc.

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.